JP2025505141A5 - - Google Patents
Info
- Publication number
- JP2025505141A5 JP2025505141A5 JP2024545807A JP2024545807A JP2025505141A5 JP 2025505141 A5 JP2025505141 A5 JP 2025505141A5 JP 2024545807 A JP2024545807 A JP 2024545807A JP 2024545807 A JP2024545807 A JP 2024545807A JP 2025505141 A5 JP2025505141 A5 JP 2025505141A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal morphology
- morphology according
- xrpd pattern
- radiation
- further characterized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306776P | 2022-02-04 | 2022-02-04 | |
| US63/306,776 | 2022-02-04 | ||
| PCT/US2023/012251 WO2023150249A1 (en) | 2022-02-04 | 2023-02-03 | Crystalline forms of an mcl-1 inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505141A JP2025505141A (ja) | 2025-02-21 |
| JP2025505141A5 true JP2025505141A5 (https=) | 2026-02-06 |
Family
ID=85570021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545807A Pending JP2025505141A (ja) | 2022-02-04 | 2023-02-03 | Ｍｃｌ－１阻害剤の結晶形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250115622A1 (https=) |
| EP (1) | EP4472984A1 (https=) |
| JP (1) | JP2025505141A (https=) |
| AU (1) | AU2023216691A1 (https=) |
| CA (1) | CA3246092A1 (https=) |
| MX (1) | MX2024009448A (https=) |
| WO (1) | WO2023150249A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4519271A1 (en) | 2022-05-04 | 2025-03-12 | Gilead Sciences, Inc. | Salts and polymorphs of certain mcl-1 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8576985B2 (en) | 2009-09-01 | 2013-11-05 | Aptuit (West Lafayette) Llc | Methods for indexing solid forms of compounds |
| JP6453507B2 (ja) | 2017-03-30 | 2019-01-16 | アムジエン・インコーポレーテツド | Ｍｃｌ−１タンパク質を阻害する化合物 |
| JP2021161114A (ja) * | 2020-03-31 | 2021-10-11 | アムジエン・インコーポレーテツド | Ｍｃｌ−１化合物のメチル化 |
-
2023
- 2023-02-03 US US18/730,357 patent/US20250115622A1/en active Pending
- 2023-02-03 CA CA3246092A patent/CA3246092A1/en active Pending
- 2023-02-03 WO PCT/US2023/012251 patent/WO2023150249A1/en not_active Ceased
- 2023-02-03 AU AU2023216691A patent/AU2023216691A1/en active Pending
- 2023-02-03 MX MX2024009448A patent/MX2024009448A/es unknown
- 2023-02-03 JP JP2024545807A patent/JP2025505141A/ja active Pending
- 2023-02-03 EP EP23710498.9A patent/EP4472984A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025176008A5 (https=) | ||
| JP2007521340A5 (https=) | ||
| US20140066466A1 (en) | Necroptosis Inhibitors and Methods of Use Therefor | |
| WO2020052627A1 (zh) | 取代的吡咯并嘧啶类cdk抑制剂的盐及其结晶和用途 | |
| RU2012138892A (ru) | СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА | |
| CN102675380A (zh) | 结晶型1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯半水合物 | |
| JP2006528973A5 (https=) | ||
| JP3476420B2 (ja) | 結晶性１−メチルカルバペネム化合物 | |
| JP2022511029A5 (https=) | ||
| JP7257328B2 (ja) | ベンゾフラン誘導体遊離塩基の結晶およびその製造方法 | |
| JP6937322B2 (ja) | 置換ピペリジン化合物の塩 | |
| JP2020536893A5 (https=) | ||
| JP2023027066A5 (https=) | ||
| CN119744262A (zh) | 哌啶基-甲基-嘌呤胺d-酒石酸盐、晶型，及其在治疗医学疾病和病况中的用途 | |
| JP2025505141A5 (https=) | ||
| JP2022534788A5 (https=) | ||
| US11286247B2 (en) | Acryloyl-containing nuclear transport regulators and uses thereof | |
| JP2025511331A5 (https=) | ||
| JP2023530786A5 (https=) | ||
| JP2024001040A5 (https=) | ||
| JP2024509276A5 (https=) | ||
| JP2025513774A5 (https=) | ||
| JP2025505142A5 (https=) | ||
| CN101506169A (zh) | 马来酸氟吡汀的药学可接受的盐及多晶型物 | |
| JP2022548689A5 (https=) |